Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

U S Physical Therapy (USPH) EBIT (2016 - 2025)

U S Physical Therapy's EBIT history spans 12 years, with the latest figure at $106000.0 for Q4 2023.

  • For Q4 2023, EBIT fell 97.68% year-over-year to $106000.0; the TTM value through Dec 2023 reached $49.4 million, down 11.37%, while the annual FY2025 figure was $77.8 million, 29.24% up from the prior year.
  • EBIT for Q4 2023 was $106000.0 at U S Physical Therapy, down from $15.8 million in the prior quarter.
  • Across five years, EBIT topped out at $22.2 million in Q2 2021 and bottomed at -$40.9 million in Q4 2019.
  • The 5-year median for EBIT is $15.9 million (2022), against an average of $12.0 million.
  • The largest annual shift saw EBIT crashed 376.04% in 2019 before it soared 274.24% in 2021.
  • A 5-year view of EBIT shows it stood at -$40.9 million in 2019, then soared by 144.54% to $18.2 million in 2020, then fell by 9.54% to $16.5 million in 2021, then crashed by 72.3% to $4.6 million in 2022, then crashed by 97.68% to $106000.0 in 2023.
  • Per Business Quant, the three most recent readings for USPH's EBIT are $106000.0 (Q4 2023), $15.8 million (Q3 2023), and $19.1 million (Q2 2023).